Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/9/2019
SIETES contiene 92806 citas

 
 
 1 a 19 de 19 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ferro A. Newer antiplatelet agents in acute coronary syndrome. BMJ 2016;352:h7025. [Ref.ID 99965]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
3.Tiene citas relacionadas Cita con resumen
Keaney Jr JF. Balancing the risks and benefits of dual platelet inhibition. N Engl J Med 2015;372:1854-6. [Ref.ID 99087]
4.Tiene citas relacionadas Cita con resumen
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, for the PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 2015;372:1791-800. [Ref.ID 99086]
5. Cita con resumen
del Castillo-Carnevali H, Barrios Alonso V, Zamorano Gómez JL. Antiagregación: resistencia a fármacos tradicionales y papel de los nuevos antiplaquetarios. Med Clin (Barc) 2014;143:222-9. [Ref.ID 97903]
6. Cita con resumen
Cohen D. FDA official: "clinical trial system is broken". BMJ 2013;347:f6980. [Ref.ID 97177]
8.
Anónimo. Ticagrelor (Brilinta) - Better than clopidogrel (Plavix)?. Med Lett Drugs Ther 2011;53:69-70. [Ref.ID 91447]
9. Cita con resumen
Anónimo. Ticagrelor for acute coronary syndrome?. Drug Ther Bull 2011;49:66-8. [Ref.ID 91221]
10.
James SK, Roe MT, Cannon CP, Cornel JH, Horrow J, Husted S, Katus H, Morais J, Steg PG, Storey RF, Stevens S, Wallentin L, Harrington RA, for the PLATO Study Group. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO. BMJ 2011;342:1403. [Ref.ID 90953]
11.Tiene citas relacionadas Cita con resumen
Wallentin L, for the PLATO genetics substudy co-authors. Genetic substudy of the PLATO trial. Authors' reply. Lancet 2011;377:637-8. [Ref.ID 90239]
12.Tiene citas relacionadas Cita con resumen
Hulot J-S, Collet J-P, Montalescot G. Genetic substudy of the PLATO trial. Lancet 2011;377:637. [Ref.ID 90238]
13.Tiene citas relacionadas Cita con resumen
Wallentin L, James S, Storey RF, Armstrong M, Barratt BJ, Horrow J, Husted S, Katus H, Steg PG, Shah SH, for the PLATO Investigators. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Lancet 2010;376:1320-8. [Ref.ID 89890]
14.Tiene citas relacionadas Cita con resumen
Fuster V, Sweeny JM. Clopidogrel and the reduced-function CYP2C19 genetic variant. JAMA 2010;304:1839-8140. [Ref.ID 89226]
15.Tiene citas relacionadas Cita con resumen
Stone GW. Ticagrelor in ACS: redefining a new standard of care?. Lancet 2010;375:263-5. [Ref.ID 87548]
16.Tiene citas relacionadas Cita con resumen
Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L, for the PLATelet inhibition and patient Outcomes (PLATO) investigators. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 2010;375:283-93. [Ref.ID 87547]
17. Cita con resumen
Schömig A. Ticagrelor-Is there need for a new player in the antiplatelet-therapy field?. N Engl J Med 2009;361:1108-11. [Ref.ID 86475]
18.Tiene citas relacionadas Cita con resumen
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KH, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, for the PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57. [Ref.ID 86474]
Seleccionar todas
 
 1 a 19 de 19